Comparison of combination therapies in the treatment of rheumatoid arthritis: Leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha

Clinical Rheumatology

Volumn 29, Issue 5, 2010, Pages 517-524

  De Stefano, Renato ^a   Frati, Elena ^a   Nargi, Fernando ^a   Baldi, Caterina ^a   Menza, Luana ^a   Hammoud, Mohammed ^a   Galeazzi, Mauro ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Combination terapy; DMARDs; Rheumatoid arthritis; TNFalpha blocking agents

Indexed keywords

ADALIMUMAB; ANTINUCLEAR ANTIBODY; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ALLERGIC VASCULITIS; AMINOTRANSFERASE BLOOD LEVEL; APPLICATION SITE REACTION; ARTHRALGIA; ARTICLE; AUTOIMMUNITY; BRAIN VASCULITIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HAIR LOSS; HERPES ZOSTER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INFECTION; INJECTION SITE REACTION; LEUKOPENIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALAISE; MALE; NAUSEA; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RASH; RHEUMATOID ARTHRITIS; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; URTICARIA; WEIGHT REDUCTION;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISOXAZOLES; MALE; METHOTREXATE; MIDDLE AGED; RISK; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950862612     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1349-y     Document Type: Article

References (28)

1. RN Maini FC Breedveld JR Kalden JS Smolen D Davis JD Mcfarlane, et al. 1998 Therapeutic efficacy of multiple intravenous infusion of anti-tumor necrosis factor alpha monoclonal antibody combined with low dose weekly methotrexate in rheumatoid arthritis Atrhritis Rheum 41 1552 1563 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W 1:CAS:528:DyaK1cXmsVChtbg%3D (Pubitemid 28459913)
2. PE Lipsky, et al. 2000 Infliximab and methotrexate in the treatment of rheumatoid arthritis N Engl J Med 343 1594 1602 10.1056/NEJM200011303432202 1:CAS:528:DC%2BD3cXovVeltLk%3D 11096166 (Pubitemid 32162982)
3. MC Genovese JM Bathon RW Martin RM Fleischmann JR Tesser MH Schiff, et al. 2002 Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes Arthritis Rheum 46 1443 1450 10.1002/art.10308 1:CAS:528:DC%2BD38Xltlantbk%3D 12115173 (Pubitemid 34620189)
4. L Klareskog D van der Heijde JP de Jager J Kalden M Malaise A Gough, et al. 2004 Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised trial Lancet 363 675 681 10.1016/S0140-6736(04)15640-7 1:CAS:528:DC%2BD2cXhs12jur4%3D 15001324 (Pubitemid 38296553)
5. FC Breedveld MH Weisman AF Kavanaugh SB Cohen K Pavelka R van Vollenhoven J Sharp JL Perez GT Spencer-Green 2006 The PREMIER study: a multicenter, randomized, doble-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Arthritis Rheum 54 1 26 37 10.1002/art.21519 1:CAS:528: DC%2BD28XhsVens74%3D 16385520 (Pubitemid 43122183)
6. ME Weinblatt EC Keystone DE Furst, et al. 2003 Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial Arthritis Rheum 48 1 35 45 10.1002/art.10697 1:CAS:528: DC%2BD3sXhtFGnsb0%3D 12528101 (Pubitemid 36091645)
7. DE Furst MH Schiff RM Fleischmann V Strand CA Birbara D Compagnone, et al. 2003 Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: result of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) J Rheumatol 30 12 2563 2571 1:CAS:528:DC%2BD2cXktVCgtbw%3D 14719195 (Pubitemid 37549331)
8. DC Nordström L Konttinen M Korpela T Tiippana-Kinnunen K Eklund S Forsberg K Ilva O Kaipiainen-Seppänen T Malmi T Ylä-Kerttula V Honkanen 2006 Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience Rheumatol Int 26 741 748 10.1007/s00296-005-0054-7 16205925 (Pubitemid 43725468)
9. A Zink J Listing S Kary, et al. 2005 Treatment continuation in patients receiving biological agents or conventional DMARD therapy Ann Rheum Dis 64 1274 1279 10.1136/ard.2004.031476 1:CAS:528:DC%2BD2MXhtVChu7zN 15708884 (Pubitemid 41206242)
10. JR O'Dell K Petersen R Leff W Palmer E Schned K Blakely C Haire A Fernandez 2006 Etanercept in combination with Sulfasalazine, Hydroxychloroquine, or Gold in the treatment of rheumatoid arthritis J Rheumatol 33 213 218 16358366 (Pubitemid 43209293)
11. B Combe C Codreanu U Fiocco M Gaubitz PP Geusens TK Kvien, et al. 2006 Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison Ann Rheum Dis 65 1357 1362 10.1136/ard.2005.049650 1:CAS:528:DC%2BD28Xht1egsLfN 16606651 (Pubitemid 44620447)
12. GR Burmester X Mariette C Montecucco I Monteagudo-Saez M Malaise AG Tzioufas, et al. 2007 Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial Ann Rheum Dis 66 732 739 10.1136/ard.2006.066761 1:CAS:528:DC%2BD2sXntlOnu7Y%3D 17329305 (Pubitemid 46846691)
13. SR Patel W Bergen A Kraemer G Keenan 2001 Efficacy and safety of remicade (infliximab) plus Arava (leflunomide) in rheumatoid arthritis Arthritis Rheum 44 Suppl 9 S84
14. PDW Kiely DM Johnson 2002 Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study Rheumatology 41 631 637 10.1093/rheumatology/41.6.631 1:CAS:528:DC%2BD38Xlt1yrsrs%3D 12048288 (Pubitemid 34618880)
15. C Struppler W Thies M Schattenkirchner H Kellner 2002 Safety and efficacy of leflunomide and infliximab in rheumatoid arthritis patients Ann Rheum Dis 61 S388
16. F Godinho B Godfrin S El Mahou F Navaux L Zabraniecki A Cantagrel 2004 Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis Clin Exp Rheumatology 22 328 330 1:STN:280:DC%2BD2c3ksFKkug%3D%3D (Pubitemid 38585235)
17. KE Hansen J Cush A Singhal DA Cooley S Cohen SR Patel M Genovese S Sundaramurthy M Schiff 2004 The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis Arthritis Rheum 51 228 232 10.1002/art.20228 1:CAS:528:DC%2BD2cXjslyltbw%3D 15077264 (Pubitemid 38468706)
18. AM Ortiz Garcia I Gonzales-Alvaro R Rosello Pardo L Carmona MD Fabregas Canales I Monteagudo Saez 2004 Effectiveness and safety of infliximab combined with leflunomide in chronic polyarthritis Clin Exp Rheumatol 22 790 1:STN:280:DC%2BD2M%2Fht1GhtQ%3D%3D 15638063 (Pubitemid 40045551)
19. SJ Bingham MH Buch MA Kerr, et al. 2004 Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide Arthritis Rheum 50 12 4072 4073 10.1002/art.20617 1:CAS:528:DC%2BD2MXls1entQ%3D%3D 15593202 (Pubitemid 39643958)
20. M Flendrie MC Creemers PM Welsing PL van Riel 2005 The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study Rheumatology 44 4 472 478 10.1093/rheumatology/keh508 1:CAS:528: DC%2BD2MXisVGqtrw%3D 15598707 (Pubitemid 41511137)
21. JR Kalden C Antoni JM Alvaro-Garcia B Combe P Emery JM Kremer CV Strand P Van Riel JS Smolen 2005 Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritis J Rheumatol 32 8 1620 1631 16078347 (Pubitemid 41113992)
22. T Cobo Ibanez M Yehia Tayel A Balsa Criado A Hernandez Sanz E Martin Mola 2005 Safety and efficacy of leflunomide and infliximab versus methotrexate and infliximab combination therapy in rheumatoid arthritis Rheumatology 44 1467 1468 10.1093/rheumatology/kei130 1:STN:280:DC%2BD2MrmslGitQ%3D%3D 16174647 (Pubitemid 41637635)
23. A Perdriger X Mariette JL Kuntz O Brocq R Kara-Terki XL Loet A Cantagrel S Pavy CJ Deslandre F Debiais B Combe 2006 Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice J Rheumatol 33 5 865 869 1:CAS:528:DC%2BD28XlsVelu7g%3D 16652418
24. M Wislowska D Jacubicz 2007 Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-alpha blocker plus methotrexate versus methotrexate or leflunomide alone Rheumatol Int 27 7 641 647 10.1007/s00296-006-0272-7 1:CAS:528:DC%2BD2sXktlSmsL0%3D 17235556 (Pubitemid 46625348)
25. JR Kalden HG Nuslein J Wollenhaupt GR Burmester K Kruger C Antoni 2008 Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis: safety and efficacy in open-label clinical trial Clin Exp Rheumatol 26 834 840 1:STN:280:DC%2BD1M%2FpvFGjtQ%3D%3D 19032816 (Pubitemid 351747130)
26. A Finckh S Dehler C Gabay on behalf of the SCQM doctors 2009 The effectiveness of leflunomide as a co-therapy of tumor necrosis factor inhibitors in rheumatoid arthritis: a population-based study Ann Rheu Dis 68 33 39 10.1136/ard.2007.085696 1:CAS:528:DC%2BD1MXhslOltrc%3D
27. A Strangfeld F Hierse J Kekow U von Hinueber HP Tony R Dockhorn J Listing A Zink 2009 Ann Rheu Dis 68 33 3
28. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper, et al. 1988 The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 334 10.1002/art.1780310302 1:STN:280:DyaL1c7pt1Ohsg%3D%3D 3358796